JBIO Jade Biosciences, Inc. - Common Stock
$23,20
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 10, 2026
52W-Spanne
$7–$28
77% of range
Analystenbewertung
STRONG BUY
17 analysts
Kursziel
$50
+116% upside
P/E (TTM)
-7.3
ROE
-47.7%
Nettogewinnmarge
—
JBIO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$23.20
Marktkapitalisierung
$1.14B
P/E (TTM)
-7.3
EPS (TTM)
$-3.19
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-47.7%
Verschuldungsgrad
—
52W-Spanne
$7 – $28
JBIO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
$-3.19
2021-12-31
→
2025-12-31
Freier Cashflow
$-95M
2021-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
JBIO
Peer-Median
P/E (TTM)
-7.3
—
P/B (K/B)
3.4
2.7
Price / FCF (Kurs / FCF)
-12.1
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
JBIO
Peer-Median
ROA
-60.3%
-43.1%
ROE
-47.7%
-49.0%
ROIC
-34.2%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
JBIO
Peer-Median
Current Ratio (Liquiditätsgrad)
21.1
9.0
Quick Ratio
20.3
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
JBIO
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
JBIO
Peer-Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Dividendenrendite
—
Ausschüttungsquote
—
5J Div CAGR
—
| Ex-Datum | Betrag |
|---|---|
| 29. April 2025 | $2,4000 |
JBIO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
17 Analysten
- Starker Kauf 8 47,1%
- Kauf 8 47,1%
- Halten 1 5,9%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
8 Analysten · 2026-08-14
Median
$47.00
Mittelwert
$50.12
← Unter allen Zielen
$23.20
Tief
$40.00
Hoch
$77.00
Median-Ziel
$47.00
+102,6%
Mittelwert-Ziel
$50.12
+116,1%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
1.0%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.57 | $-0.49 | -0.08% |
| 31. Dezember 2025 | $-0.59 | $-0.48 | -0.11% |
| 30. September 2025 | $-0.48 | $-0.69 | 0.21% |
| 30. Juni 2025 | $-0.86 | $-0.44 | -0.42% |
| 31. März 2025 | $-3.15 | $-8.57 | 5.4% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| JBIO | $761M | -4.8 | — | — | -47.7% | — |
| PURR | — | — | — | — | — | — |
| VIR | $841M | -1.9 | -7.6% | -638.9% | -51.1% | — |
| ORIC | $806M | -5.6 | — | — | -36.5% | — |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | — |
| AVBP | $854M | -4.7 | — | — | -59.7% | — |
| REPL | $633M | -2.3 | — | — | -146.2% | — |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | — |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | — |
| CGEM | $624M | -3.2 | — | — | -44.0% | — |
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $93M | $53M | $64M | $39M | $15M | $8M | |
| SG&A Expense | $20M | $21M | $17M | $15M | $8M | $949.0K | |
| Operating Expenses | $114M | $75M | $81M | $53M | $23M | $9M | |
| Operating Income | $-114M | $-75M | $-81M | $-53M | $-23M | $-9M | |
| Interest Expense | · | · | · | · | · | $75.0K | |
| Other Non-op | $-8.0K | $-19.0K | $-1.0K | $2M | $62.0K | $-722.0K | |
| Pretax Income | $-127M | $-70M | $-75M | $-51M | $-23M | $-10M | |
| Income Tax | $58.0K | $55.0K | $56.0K | $25.0K | $3.0K | · | |
| Net Income | $-127M | $-70M | $-76M | $-52M | $-23M | $-10M | |
| EPS (Basic) | $-3.19 | $-2.44 | $-2.87 | $-2.10 | $-1.87 | · | |
| EPS (Diluted) | $-3.19 | $-2.44 | $-2.87 | $-2.10 | $-1.87 | · | |
| Shares (Basic) | 31,359,958 | 28,582,194 | 26,331,630 | 24,472,104 | 12,293,629 | · | |
| Shares (Diluted) | 31,359,958 | 28,582,194 | 26,331,630 | 24,472,104 | 12,293,629 | · | |
| EBITDA | $-114M | $-75M | $-81M | $-53M | $-23M | · |
Bilanz 21
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $88M | $69M | $23M | $22M | $54M | $5M | |
| Short-term Investments | $248M | $0 | $99M | $107M | $113M | · | |
| Prepaid Expense | $13M | $268.0K | $2M | $2M | $7M | $103.0K | |
| Current Assets | $349M | $70M | $124M | $131M | $174M | $5M | |
| PP&E (Net) | $170.0K | · | $288.0K | $242.0K | $186.0K | $39.0K | |
| PP&E (Gross) | · | · | · | · | · | $40.0K | |
| Accum. Depreciation | · | · | · | · | · | $1.0K | |
| Other Non-current Assets | $69.0K | $3M | $2M | $3M | $302.0K | · | |
| Total Assets | $350M | $73M | $127M | $135M | $175M | $5M | |
| Accounts Payable | $2M | $1M | $2M | $3M | $1M | $618.0K | |
| Accrued Liabilities | $9M | $4M | · | · | · | · | |
| Current Liabilities | $17M | $12M | $18M | $8M | $3M | $2M | |
| Capital Leases | $724.0K | $0 | $255.0K | $705.0K | $382.0K | · | |
| Total Liabilities | $17M | $120M | $18M | $9M | $3M | $2M | |
| Common Stock | $5.0K | $1.0K | $3.0K | $2.0K | $2.0K | · | |
| Paid-in Capital | $507M | $179.0K | $273M | $215M | $209M | $63.0K | |
| Retained Earnings | $-174M | $-47M | $-163M | $-88M | $-36M | $-13M | |
| AOCI | $129.0K | $0 | $237.0K | $-466.0K | $-59.0K | · | |
| Stockholders' Equity | $333M | $-47M | $109M | $127M | $172M | $-13M | |
| Liabilities + Equity | $350M | $73M | $127M | $135M | $175M | $5M | |
| Shares Outstanding | 49,316,287 | 3,672,794 | 27,762,703 | 24,722,974 | 24,410,393 | 243,076 |
Cashflow 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $20M | $11M | $12M | $5M | $2M | $58.0K | |
| Deferred Tax | $-44.0K | · | · | · | · | · | |
| Operating Cash Flow | $-95M | $-71M | $-57M | $-39M | $-27M | $-8M | |
| CapEx | $196.0K | · | $142.0K | $195.0K | $181.0K | · | |
| Investing Cash Flow | $-247M | $56M | $12M | $7M | $-113M | · | |
| Stock Issued | · | $24M | $45M | · | $127M | · | |
| Net Stock Activity | · | $24M | $45M | · | $127M | · | |
| Financing Cash Flow | $361M | $25M | $46M | $396.0K | $190M | $9M | |
| Net Change in Cash | $19M | $10M | $1M | $-32M | $50M | $1M | |
| Free Cash Flow | $-95M | · | $-57M | $-39M | $-28M | · |
Rentabilität 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -60.3% | -67.0% | -57.5% | -33.2% | -25.5% | · | |
| ROE | -47.7% | -233.8% | -64.2% | -38.8% | -13.0% | · | |
| ROIC | -34.2% | -97.7% | -74.4% | -42.0% | -13.4% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 21.1 | 20.9 | 7.0 | 16.9 | 68.4 | · | |
| Quick Ratio | 20.3 | 20.5 | 6.9 | 16.6 | 65.6 | · |
Bewertung (TTM) 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-127M | $-70M | $-76M | $-52M | $-23M | · | |
| Market Cap | $761M | $2.69B | $21.99B | $25.35B | $10.07B | · | |
| P/E | -4.8 | -38.0 | -276.0 | -488.3 | -220.7 | · | |
| P/B | 2.3 | 35.2 | 200.9 | 200.0 | 58.4 | · | |
| P / Tangible Book | 2.3 | · | 200.9 | 200.0 | 58.4 | · | |
| P / Cash Flow | -8.0 | -37.8 | -387.3 | -648.1 | -367.6 | · | |
| P / FCF | -8.0 | · | -386.3 | -644.8 | -365.2 | · | |
| Earnings Yield | -20.7% | -2.6% | -0.36% | -0.20% | -0.45% | · |
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $50M | $36M | $29M | $22M | $23M | $20M | $-2M | $14M | $21M | $20M | $18M | $17M | $16M | $13M | $12M | $11M | |
| SG&A Expense | $9M | $7M | $6M | $5M | $5M | $3M | $11M | $1M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $3M | |
| Operating Expenses | $59M | $43M | $55M | $27M | $28M | $23M | $9M | $15M | $26M | $25M | $22M | $21M | $20M | $18M | $16M | $14M | |
| Operating Income | $-59M | $-43M | $-55M | $-27M | $-28M | $-23M | $-9M | $-15M | $-26M | $-25M | $-22M | $-21M | $-20M | $-18M | $-16M | $-14M | |
| Other Non-op | $-62.0K | $-9.0K | $4M | $-28.0K | $0 | $0 | $-1M | $0 | $1M | $-3.0K | $-2M | $1.0K | $1M | $1M | $2M | $4.0K | |
| Pretax Income | $-56M | $-40M | · | · | $-32M | $-38M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $15.0K | $16.0K | $58.0K | $0 | $0 | · | · | $0 | · | · | · | · | · | · | · | · | |
| Net Income | $-56M | $-40M | $-32M | $-25M | $-32M | $-38M | $-5M | $-16M | $-25M | $-23M | $-20M | $-20M | $-19M | $-17M | $-15M | $-14M | |
| EPS (Basic) | $-0.76 | $-0.57 | $-1.76 | $-0.48 | $-0.86 | $-12.10 | $4.41 | $-5.16 | $-0.86 | $-0.83 | $-0.73 | $-0.71 | $-0.76 | $-0.67 | $-0.60 | $-0.56 | |
| EPS (Diluted) | $-0.76 | $-0.57 | $-1.76 | $-0.48 | $-0.86 | $-12.10 | $4.41 | $-5.16 | $-0.86 | $-0.83 | $-0.73 | $-0.71 | $-0.76 | $-0.67 | $-0.60 | $-0.56 | |
| Shares (Basic) | 61,050,775 | 57,777,165 | -65,640,708 | 39,584,489 | 28,431,158 | 3,155,500 | -31,125,176 | 3,155,500 | 28,756,043 | 27,795,827 | -51,253,264 | 27,640,542 | 25,166,505 | 24,777,847 | -48,803,578 | 24,454,786 | |
| Shares (Diluted) | 61,050,775 | 57,777,165 | -65,640,708 | 39,584,489 | 28,431,158 | 3,155,500 | -31,125,176 | 3,155,500 | 28,756,043 | 27,795,827 | -51,253,264 | 27,640,542 | 25,166,505 | 24,777,847 | -48,803,578 | 24,454,786 | |
| EBITDA | $-59M | $-43M | · | $-27M | $-28M | $-3M | · | $-17M | $-26M | $-25M | · | $-21M | $-20M | $-18M | · | $-14M |
Bilanz 19
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $107M | $55M | $88M | $50M | $221M | $44M | $34M | $31M | $31M | $9M | $23M | $32M | $61M | $27M | $22M | $22M | |
| Short-term Investments | $354M | $256M | $248M | $149M | · | $32M | $45M | $58M | $73M | $90M | $99M | $103M | $89M | $92M | $107M | $120M | |
| Prepaid Expense | $10M | $7M | $13M | $2M | $2M | $1M | $1M | $2M | $7M | $4M | $2M | $2M | $2M | $2M | $2M | $3M | |
| Current Assets | $471M | $319M | $349M | $201M | $223M | $77M | $80M | $91M | $111M | $103M | $124M | $138M | $152M | $121M | $131M | $145M | |
| PP&E (Net) | $144.0K | $157.0K | $170.0K | $176.0K | $147.0K | $2.0K | $6.0K | $14.0K | $232.0K | $260.0K | $288.0K | $316.0K | $245.0K | $267.0K | $242.0K | $330.0K | |
| Other Non-current Assets | $69.0K | $69.0K | $69.0K | $174.0K | $60.0K | · | · | $81.0K | $81.0K | $3M | $2M | $2M | $2M | $3M | $3M | $1M | |
| Total Assets | $472M | $319M | $350M | $202M | $224M | $78M | $80M | $91M | $112M | $107M | $127M | $141M | $156M | $124M | $135M | $148M | |
| Accounts Payable | $7M | $4M | $2M | $1M | $8M | $69.0K | $224.0K | $908.0K | $4M | $3M | $2M | $4M | $6M | $5M | $3M | $5M | |
| Accrued Liabilities | $15M | $15M | $9M | $14M | $8M | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $32M | $22M | $17M | $22M | $22M | $2M | $4M | $10M | $17M | $16M | $18M | $15M | $13M | $11M | $8M | $8M | |
| Capital Leases | $628.0K | $679.0K | $724.0K | $747.0K | $792.0K | · | · | $81.0K | $206.0K | $329.0K | $255.0K | $358.0K | $476.0K | $591.0K | $705.0K | $800.0K | |
| Total Liabilities | $32M | $23M | $17M | $23M | $22M | $2M | $4M | $10M | $17M | $16M | $18M | $15M | $14M | $11M | $9M | $9M | |
| Common Stock | $6.0K | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | |
| Paid-in Capital | $711M | $512M | $507M | $322M | $319M | $311M | $309M | $308M | $306M | $278M | $273M | $269M | $266M | $218M | $215M | $213M | |
| Retained Earnings | $-271M | $-215M | $-174M | $-142M | $-117M | $-236M | $-233M | $-228M | $-211M | $-187M | $-163M | $-143M | $-123M | $-104M | $-88M | $-73M | |
| AOCI | $-660.0K | $-342.0K | $129.0K | $29.0K | $-24.0K | $50.0K | $105.0K | $224.0K | $-83.0K | $-33.0K | $237.0K | $-195.0K | $-223.0K | $-201.0K | $-466.0K | $-771.0K | |
| Stockholders' Equity | $440M | $296M | $333M | $179M | $202M | $75M | $76M | $80M | $94M | $91M | $109M | $126M | $142M | $113M | $127M | $139M | |
| Liabilities + Equity | $472M | $319M | $350M | $202M | $224M | $78M | $80M | $91M | $112M | $107M | $127M | $141M | $156M | $124M | $135M | $148M | |
| Shares Outstanding | 63,556,065 | 49,345,967 | 49,316,287 | 32,626,730 | 32,626,730 | 28,985,019 | 28,985,019 | 28,867,711 | 28,854,750 | 27,898,761 | 27,762,703 | 27,653,187 | 27,601,098 | 24,816,940 | 24,722,974 | 24,506,390 |
Cashflow 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $14M | $7M | $11M | $4M | $4M | $2M | $3M | $27.0K | $4M | $4M | $3M | $3M | $3M | $2M | $2M | $1M | |
| Operating Cash Flow | $-44M | $-24M | $-34M | $-22M | $-37M | $-19M | $-11M | $-7M | $-20M | $-24M | $-15M | $-16M | $-15M | $-11M | $-15M | $-10M | |
| CapEx | · | · | $3.0K | $57.0K | · | · | · | · | · | · | $64.0K | $32.0K | $30.0K | $16.0K | $4.0K | $33.0K | |
| Investing Cash Flow | $-98M | $-8M | $-98M | $-149M | $-13M | $13M | $13M | $0 | $18M | $9M | $6M | $-13M | $4M | $15M | $14M | $5M | |
| Stock Issued | · | · | · | · | · | · | $307.0K | $0 | · | · | $0 | $0 | · | · | · | · | |
| Financing Cash Flow | $194M | $-795.0K | $170M | $0 | $191M | $-700.0K | $554.0K | $95M | $24M | $471.0K | $463.0K | $20.0K | $45M | $223.0K | $357.0K | $37.0K | |
| Net Change in Cash | $52M | $-33M | $38M | $-171M | $141M | $-19M | $3M | $88M | $22M | $-14M | $-9M | $-29M | $34M | $4M | $-22.0K | $-5M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-11M | · | · |
Rentabilität 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -16.0% | -20.3% | · | -17.2% | -19.1% | -2.7% | · | -14.0% | -18.5% | -20.1% | · | -13.6% | -12.2% | -11.3% | · | -8.2% | |
| ROE | -17.4% | -21.7% | · | -19.4% | -21.7% | -3.0% | · | -15.8% | -21.0% | -22.7% | · | -14.8% | -13.0% | -12.0% | · | -8.5% | |
| ROIC | -13.4% | -14.7% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.9 | 14.3 | · | 9.0 | 10.3 | 32.0 | · | 8.8 | 6.5 | 6.7 | · | 9.3 | 11.5 | 11.3 | · | 18.8 | |
| Quick Ratio | 14.6 | 14.0 | · | 8.9 | 10.2 | 31.5 | · | 8.6 | 6.1 | 6.4 | · | 9.2 | 11.3 | 11.2 | · | 18.5 |
Bewertung (TTM) 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-153M | $-136M | · | $-112M | $-111M | $-102M | · | $-84M | $-87M | $-78M | · | $-69M | $-61M | $-53M | · | $-43M | |
| Market Cap | $1.41B | $693M | · | $282M | $326M | $2.55B | · | $2.11B | $1.68B | $28.87B | · | $13.13B | $16.57B | $17.52B | · | $14.22B | |
| P/E | -8.3 | -1.0 | · | -1.3 | -1.4 | -12.7 | · | -9.7 | -18.4 | -348.5 | · | -175.9 | -242.0 | -325.3 | · | -329.7 | |
| P/B | 3.2 | 2.3 | · | 1.6 | 1.6 | 33.9 | · | 26.2 | 17.8 | 317.6 | · | 104.5 | 116.7 | 154.9 | · | 102.2 | |
| P / Tangible Book | 3.2 | 2.3 | · | 1.6 | 1.6 | 33.9 | · | 26.2 | 17.8 | 317.6 | · | 104.5 | 116.7 | 154.9 | · | 102.2 | |
| P / Cash Flow | · | -28.8 | · | · | · | -1069.4 | · | · | · | -1219.7 | · | · | · | -1533.6 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -1531.4 | · | · | |
| Earnings Yield | -12.0% | -99.7% | · | -76.4% | -69.8% | -7.9% | · | -10.3% | -5.4% | -0.29% | · | -0.57% | -0.41% | -0.31% | · | -0.30% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Nettoergebnis | $-127M | $-70M | $-76M | $-52M | $-23M |
| Verwässerte EPS | $-3.19 | $-2.44 | $-2.87 | $-2.10 | $-1.87 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 21.1 | 20.9 | 7.0 | 16.9 | 68.4 |
| Quick Ratio | 20.3 | 20.5 | 6.9 | 16.6 | 65.6 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-95M | — | $-57M | $-39M | $-28M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 161 Einreicher · $1.3B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 58 (+29 vs. Vorquartal) | 15 (+4 vs. Vorquartal) | 52 (+16 vs. Vorquartal) | 26 (-3 vs. Vorquartal) | +12.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $160.922.573 | 7.242.240 | 12,56% | Aktien |
| Fairmount Funds Management LLC | $101.178.637 | 4.553.494 | 7,90% | Aktien |
| RA CAPITAL MANAGEMENT, L.P. | $81.571.464 | 3.671.083 | 6,37% | Aktien |
| Venrock Adviser, LLC | $71.556.488 | 3.220.364 | 5,59% | Aktien |
| Bellevue Group AG | $67.948.671 | 3.057.996 | 5,31% | Aktien |
| Paradigm Biocapital Advisors LP | $63.491.539 | 2.857.405 | 4,96% | Aktien |
| STATE STREET CORP | $51.890.033 | 2.335.285 | 4,05% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $49.878.856 | 2.244.773 | 3,89% | Aktien |
| JANUS HENDERSON GROUP PLC | $43.557.008 | 3.105.669 | 3,40% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $42.458.243 | 1.910.812 | 3,31% | Aktien |
| Polar Capital Holdings Plc | $41.039.940 | 1.846.982 | 3,20% | Aktien |
| Avidity Partners Management LP | $37.789.732 | 1.700.708 | 2,95% | Aktien |
| Remedium Capital Partners, LLC | $35.057.605 | 1.577.750 | 2,74% | Aktien |
| Soleus Capital Management, L.P. | $34.456.332 | 1.550.690 | 2,69% | Aktien |
| BAKER BROS. ADVISORS LP | $27.340.066 | 1.230.426 | 2,13% | Aktien |
| Logos Global Management LP | $24.997.500 | 1.125.000 | 1,95% | Aktien |
| Versant Venture Management, LLC | $22.037.418 | 991.783 | 1,72% | Aktien |
| ACORN CAPITAL ADVISORS, LLC | $21.925.807 | 986.760 | 1,71% | Aktien |
| Foresite Capital Management VI LLC | $19.701.741 | 886.667 | 1,54% | Aktien |
| Balyasny Asset Management L.P. | $19.525.292 | 878.726 | 1,52% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $18.744.951 | 843.337 | 1,46% | Aktien |
| Affinity Asset Advisors, LLC | $18.672.577 | 840.350 | 1,46% | Aktien |
| SAMSARA BIOCAPITAL, LLC | $16.359.186 | 736.237 | 1,28% | Aktien |
| Pictet Asset Management Holding SA | $16.304.325 | 733.768 | 1,27% | Aktien |
| Aberdeen Group plc | $13.801.020 | 621.108 | 1,08% | Aktien |
| GOLDMAN SACHS GROUP INC | $13.387.928 | 602.517 | 1,05% | Aktien |
| MARSHALL WACE, LLP | $12.342.966 | 555.489 | 0,96% | Aktien |
| CITADEL ADVISORS LLC | $12.093.546 | 544.264 | 0,94% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $10.255.152 | 461.528 | 0,80% | Aktien |
| BANK OF AMERICA CORP /DE/ | $10.088.569 | 454.031 | 0,79% | Aktien |
| Blackstone Inc. | $9.672.810 | 435.320 | 0,76% | Aktien |
| Ikarian Capital, LLC | $9.495.694 | 427.349 | 0,74% | Aktien |
| Walleye Capital LLC | $8.116.344 | 365.272 | 0,63% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $6.989.257 | 314.548 | 0,55% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $6.774.145 | 304.867 | 0,53% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $4.825.229 | 217.157 | 0,38% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $4.431.312 | 199.429 | 0,35% | Aktien |
| Point72 Asset Management, L.P. | $3.715.273 | 167.204 | 0,29% | Aktien |
| Opaleye Management Inc. | $3.221.900 | 145.000 | 0,25% | Aktien |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $3.114.989 | 140.886 | 0,24% | Aktien |
| Quantinno Capital Management LP | $2.548.990 | 114.716 | 0,20% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $2.504.261 | 112.703 | 0,20% | Aktien |
| VANGUARD GROUP INC | $2.491.621 | 161.479 | 0,19% | Aktien |
| Sofinnova Investments, Inc. | $2.386.228 | 107.391 | 0,19% | Aktien |
| AMERIPRISE FINANCIAL INC | $2.378.718 | 107.053 | 0,19% | Aktien |
| Woodline Partners LP | $2.227.977 | 100.269 | 0,17% | Aktien |
| SEVEN GRAND MANAGERS, LLC | $2.222.000 | 100.000 | 0,17% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.221.489 | 99.977 | 0,17% | Aktien |
| Atle Fund Management AB | $1.967.714 | 88.556 | 0,15% | Aktien |
| Swiss National Bank | $1.850.926 | 83.300 | 0,14% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $1.749.225 | 78.723 | 0,14% | Aktien |
| Longaeva Partners L.P. | $1.744.292 | 78.501 | 0,14% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.635.192 | 73.591 | 0,13% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $1.532.736 | 68.980 | 0,12% | Aktien |
| Trexquant Investment LP | $1.517.982 | 68.316 | 0,12% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.517.626 | 68.300 | 0,12% | Verkaufsoption |
| Harvest Investment Services, LLC | $1.399.482 | 62.983 | 0,11% | Aktien |
| Corient Private Wealth LP | $1.365.199 | 61.440 | 0,11% | Aktien |
| XTX Topco Ltd | $1.313.046 | 59.093 | 0,10% | Aktien |
| Verdad Advisers, LP | $1.252.852 | 56.384 | 0,10% | Aktien |
| Squarepoint Ops LLC | $1.210.012 | 54.456 | 0,09% | Aktien |
| CITIGROUP INC | $1.166.506 | 52.498 | 0,09% | Aktien |
| Maven Securities LTD | $1.111.000 | 50.000 | 0,09% | Aktien |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $1.074.870 | 48.374 | 0,08% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $1.007.921 | 45.361 | 0,08% | Aktien |
| Rafferty Asset Management, LLC | $947.216 | 42.629 | 0,07% | Aktien |
| RHUMBLINE ADVISERS | $908.965 | 40.908 | 0,07% | Aktien |
| Russell Investments Group, Ltd. | $869.734 | 39.141 | 0,07% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $812.963 | 36.587 | 0,06% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $797.698 | 35.900 | 0,06% | Kaufoption |
| Vanguard Global Advisers, LLC | $757.546 | 34.093 | 0,06% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $702.441 | 31.613 | 0,05% | Aktien |
| BlackRock, Inc. | $673.999 | 30.333 | 0,05% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $664.987 | 47.330 | 0,05% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $635.003 | 28.578 | 0,05% | Aktien |
| Voleon Capital Management LP | $617.205 | 27.777 | 0,05% | Aktien |
| Man Group plc | $580.453 | 26.123 | 0,05% | Aktien |
| D. E. Shaw & Co., Inc. | $526.614 | 23.700 | 0,04% | Aktien |
| Engineers Gate Manager LP | $502.594 | 22.619 | 0,04% | Aktien |
| Aquatic Capital Management LLC | $498.417 | 22.431 | 0,04% | Aktien |
| BARCLAYS PLC | $485.285 | 21.840 | 0,04% | Aktien |
| PROFUND ADVISORS LLC | $475.775 | 21.412 | 0,04% | Aktien |
| Virtus Investment Advisers, LLC | $473.930 | 21.329 | 0,04% | Aktien |
| Bank of New York Mellon Corp | $454.221 | 20.442 | 0,04% | Aktien |
| Ghisallo Capital Management LLC | $444.400 | 20.000 | 0,03% | Aktien |
| MetLife Investment Management, LLC | $438.601 | 19.739 | 0,03% | Aktien |
| KLP KAPITALFORVALTNING AS | $306.636 | 13.800 | 0,02% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $292.037 | 13.143 | 0,02% | Aktien |
| Invesco Ltd. | $284.327 | 12.796 | 0,02% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $256.019 | 11.522 | 0,02% | Aktien |
| State of New Jersey Common Pension Fund D | $221.445 | 9.966 | 0,02% | Aktien |
| Brevan Howard Capital Management LP | $215.623 | 9.704 | 0,02% | Aktien |
| DELTEC ASSET MANAGEMENT LLC | $209.668 | 9.436 | 0,02% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $204.824 | 9.218 | 0,02% | Aktien |
| UBS Group AG | $194.936 | 8.773 | 0,02% | Aktien |
| Vanguard Investments Australia, Ltd. | $173.916 | 7.827 | 0,01% | Aktien |
| Nuveen, LLC | $136.742 | 6.154 | 0,01% | Aktien |
| NORTHERN TRUST CORP | $113.633 | 5.114 | 0,01% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $109.545 | 4.930 | 0,01% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $109.489 | 4.952 | 0,01% | Aktien |
Unternehmensinsider 20 Insider · 4 Führungskräfte · 9 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Tom Frohlich | Chief Executive Officer | 12. Februar 2026 A | 86.331 | 0 | 0 | $0 |
| Bradford D. Dahms | Chief Financial Officer | 12. Februar 2026 A | 37.813 | 0 | 0 | $0 |
| Elizabeth Balta | Chief Legal Officer and Corporate Secretary | 12. Februar 2026 A | 28.125 | 0 | 0 | $0 |
| Andrew James King | Chief Scientific Officer & Head of Research and Development | 12. Februar 2026 A | 386.113 | 0 | 0 | $0 |
| Mark Eisner | Direktor | 25. Juni 2026 A | — | 0 | 0 | $0 |
| Christopher W. Cain | Direktor | 9. Juni 2026 A | — | 0 | 0 | $0 |
| Lawrence Otto Klein | Direktor | 9. Juni 2026 A | — | 0 | 0 | $0 |
| Erin Lavelle | Direktor | 9. Juni 2026 A | — | 0 | 0 | $0 |
| Eric Dobmeier | Direktor | 9. Juni 2026 A | — | 0 | 0 | $0 |
| Allison Dorval | Direktor | 15. Juli 2021 A | — | 0 | 0 | $0 |
| David S. Grayzel | Direktor | 2. Juli 2021 C | 3.103.879 | 0 | 0 | $0 |
| Dr. Maha Katabi | Direktor | 2. Juli 2021 C | 3.758.686 | 0 | 0 | $0 |
| Atlas Venture Fund XII, L.P. | 10%-Eigentümer | 15. Juli 2022 J | 2.327.909 | 0 | 0 | $0 |
| Benjamin T Dake | — | 29. Juni 2021 A | — | 0 | 0 | $0 |
| Hunter Gillies | — | 29. Juni 2021 A | — | 0 | 0 | $0 |
| Joshua Resnick | — | 29. Juni 2021 A | — | 0 | 0 | $0 |
| Mark T Iwicki | — | 29. Juni 2021 A | — | 0 | 0 | $0 |
| George A Eldridge | — | 29. Juni 2021 A | — | 0 | 0 | $0 |
| Timothy P Noyes | — | 29. Juni 2021 A | — | 0 | 0 | $0 |
| Ralph Niven | — | 29. Juni 2021 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Fairmount Healthcare Co-Invest IV L.P., Peter Evan Harwin, Tomas Kiselak ×3 Einreichungen | 9. Juni 2026 | 19,99% | Änderung | — | SEC |
| Sofinnova Venture Partners X, L.P. ("SVP X"), Sofinnova Management X, L.P. ("SM X LP"), Sofinnova Management X-A, L.L.C. ("SM X LLC"), Dr. James I. Healy ("Healy"), Dr. Maha Katabi ("Katabi") | 5. März 2026 | 0,30% | Änderung | Passive Anlage | SEC |
| Atlas Venture Fund XII, L.P., Atlas Venture Associates XII, L.P., Atlas Venture Associates XII, LLC ×5 Einreichungen | 30. April 2025 | 0,20% | Änderung | — | SEC |
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 Einreichungen | 30. April 2025 | 4,10% | Änderung | — | SEC |
| Sofinnova Venture Partners X, L.P. (“SVP X”), Sofinnova Management X, L.P. (“SM X LP”), Sofinnova Management X-A, L.L.C. (“SM X LLC”), Dr. James I. Healy (“Healy”), Dr. Maha Katabi (“Katabi”) ×3 Einreichungen | 20. Februar 2024 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 24 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 1,20% | 18.425 NS | 30. April 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0,17% | 90.180 NS | 30. April 2026 | N-PORT |
| IWC · iShares Trust | 0,16% | 110.226 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,12% | 111.509 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,04% | 291.651 SH | 8. August 2026 | Täglich |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,04% | 53.058 NS | 31. Mai 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,04% | 34.886 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,02% | 834.822 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 187.416 SH | 8. August 2026 | Täglich |
| ISCB · iShares Trust | 0,02% | 2.353 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,02% | 1.500 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 489.225 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 124.984 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,01% | 1.173 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 3.435 NS | 31. Mai 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 2.542 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,01% | 1.189 NS | 31. Mai 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 25.716 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 30 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 71.137 SH | 8. August 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 14.895 SH | 8. August 2026 | Täglich |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 5.087 NS | 31. Mai 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.699.343 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.733 SH | 8. August 2026 | Täglich |